208 related articles for article (PubMed ID: 37578237)
1. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
Mori S; Ishii Y; Takeuchi T; Kukimoto I
J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
[TBL] [Abstract][Full Text] [Related]
2. The Transcriptional Cofactor VGLL1 Drives Transcription of Human Papillomavirus Early Genes via TEAD1.
Mori S; Takeuchi T; Ishii Y; Kukimoto I
J Virol; 2020 May; 94(10):. PubMed ID: 32132238
[TBL] [Abstract][Full Text] [Related]
3. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
[TBL] [Abstract][Full Text] [Related]
4. The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.
Song Z; Cui Y; Li Q; Deng J; Ding X; He J; Liu Y; Ju Z; Fang L
Virol J; 2021 May; 18(1):94. PubMed ID: 33941222
[TBL] [Abstract][Full Text] [Related]
5. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
7. Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control.
Thakur K; Janjua D; Aggarwal N; Chhokar A; Yadav J; Tripathi T; Chaudhary A; Senrung A; Shrivastav A; Bharti AC
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166817. PubMed ID: 37532113
[TBL] [Abstract][Full Text] [Related]
8. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
9. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
Zhao J; Zhu J; Guo J; Zhu T; Zhong J; Liu M; Ruan Y; Liao S; Li F
J Med Virol; 2020 Mar; 92(3):372-381. PubMed ID: 31670402
[TBL] [Abstract][Full Text] [Related]
13. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
Yew CW; Lee P; Chan WK; Lim VK; Tay SK; Tan TM; Deng LW
Cancer Res; 2011 Nov; 71(21):6696-707. PubMed ID: 21908553
[TBL] [Abstract][Full Text] [Related]
14. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
[TBL] [Abstract][Full Text] [Related]
16. Repression of Memo1, a Novel Target of Human Papillomavirus Type 16 E7, Increases Cell Proliferation in Cervical Cancer Cells.
Trejo-Cerro O; Massimi P; Broniarczyk J; Myers M; Banks L
J Virol; 2022 Oct; 96(20):e0122922. PubMed ID: 36197110
[TBL] [Abstract][Full Text] [Related]
17. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
18. Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.
Evande R; Rana A; Biswas-Fiss EE; Biswas SB
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239839
[TBL] [Abstract][Full Text] [Related]
19. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
